<code id='78C32C9BA4'></code><style id='78C32C9BA4'></style>
    • <acronym id='78C32C9BA4'></acronym>
      <center id='78C32C9BA4'><center id='78C32C9BA4'><tfoot id='78C32C9BA4'></tfoot></center><abbr id='78C32C9BA4'><dir id='78C32C9BA4'><tfoot id='78C32C9BA4'></tfoot><noframes id='78C32C9BA4'>

    • <optgroup id='78C32C9BA4'><strike id='78C32C9BA4'><sup id='78C32C9BA4'></sup></strike><code id='78C32C9BA4'></code></optgroup>
        1. <b id='78C32C9BA4'><label id='78C32C9BA4'><select id='78C32C9BA4'><dt id='78C32C9BA4'><span id='78C32C9BA4'></span></dt></select></label></b><u id='78C32C9BA4'></u>
          <i id='78C32C9BA4'><strike id='78C32C9BA4'><tt id='78C32C9BA4'><pre id='78C32C9BA4'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:115
          Two researchers look at a computer monitor showing a graph and other data
          Adobe

          Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

          Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

          advertisement

          The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Fed up with FDA, ALS advocates consider a take
          Fed up with FDA, ALS advocates consider a take

          Ademonstrationmarkingthe10thanniversaryoftheformationACTUP,inNewYork.MarkLennihan/APWASHINGTON—NextW

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Midwives could help bridge maternal health disparities in the U.S.

          HANNAHMCKAY/POOL/AFPviaGettyImagesInthewakeofgrowingalarmoverthedisproportionatelyhighratesofmaterna